Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cymabay Therapeutics (NQ: CBAY )

2.770 -0.180 (-6.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 387,307
Open 2.940
Bid (Size) 2.770 (4)
Ask (Size) 2.850 (10)
Prev. Close 2.950
Today's Range 2.765 - 2.980
52wk Range 1.670 - 4.740
Shares Outstanding 84,677,939
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash. 
Via Benzinga

Performance

YTD
-23.90%
-23.90%
1 Month
+42.05%
+42.05%
3 Month
-18.29%
-18.29%
6 Month
-23.90%
-23.90%
1 Year
-34.36%
-34.36%

More News

Read More
CymaBay's New Seladelpar Two-Year Data Shows Improved Transplant-Free Survival
Via Benzinga
CymaBay Therapeutics: Q1 Earnings Insights
Via Benzinga
79 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill
Via Benzinga
CymaBay Therapeutics: Q4 Earnings Insights
Via Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Via Benzinga
Earnings Scheduled For March 17, 2022
Via Benzinga
A Preview Of CymaBay Therapeutics's Earnings
Via Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Drops 2%; Limelight Networks Shares Spike Higher
Via Benzinga
Mid-Day Market Update: Dow Falls 100 Points; Netflix Shares Plummet
Via Benzinga
34 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Down; Schlumberger Earnings Top Views
Via Benzinga
4 Penny Stocks Insiders Are Buying: CymaBay Therapeutics, Avalo Therapeutics And More
Via Benzinga
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
Via Benzinga
CymaBay Therapeutics Inc. (CBAY) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.